Ariad Pharmaceuticals, Inc. (ARIA) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Join SI Premium – FREE
Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) reported Q3 EPS of $0.10, $0.05 better than the analyst estimate of $0.05. Revenue for the quarter came in at $25.1 million versus the consensus estimate of $26.13 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Procter & Gamble (PG) revenue falls short of expectations, raises full-year earnings guidance
- Oilfield firm SLB's profit rises on international drilling demand
- Glacier Bancorp (GBCI) Misses Q1 EPS by 3c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
